Several multiple sclerosis drugs covered by Pharmacare in every province except B.C.
When Deborah Stefanek was 38 years old, the mother of four from Kimberley, B.C. was diagnosed with relapsing remitting multiple sclerosis.
That was in 2018, and she hoped a healthy lifestyle would enable her to stay off medication. She changed her diet and started an exercise routine. But after an MRI last fall showed her disease is progressing, Stefanek’s neurologist recommended she begin taking a new medication called Kisempta.
The drug’s manufacturer agreed to temporarily provide the medication free of charge while Stefanek looked into coverage through Pharmacare and private insurance.
“And it came back that my husband’s insurance would only cover 45 per cent of the cost of Kesimpta, which would mean we would have to pay $19,000 out of pocket, because B.C. Pharmacare doesn’t cover it,” said Stefanek.
She was shocked to learn every province in Canada covers Kisempta under their Pharmacare plans except B.C. It’s the same situation for a similar drug called Ocrevus. Stefanek’s friend Andrea Rollheiser, who also has RRMS, was told by her neurologist that Ocrevus is the best drug for her, but it too isn’t covered by B.C. Pharmacare.
The province’s health critic Shirley Bond says that’s unacceptable.
“As patients in British Columbians look across the country, British Columbia is an island on this issue unto itself. And it very hard for people to understand why other jurisdictions, including the one next door to us, can figure out how to cover these drugs,” said Bond, who believes it’s all about cost.
Roche Canada, the maker of Ocrevus, is hoping the B.C. government will reverse course and cover both drugs, which are approved by Health Canada and have been proven to reduce the number and severity of MS relapses.
“All of the other provincial governments have made the decision to make this medicine available, they felt it was a valuable medicine for those living with MS in thier province. And we are equally hopeful that we can have a discussion with the government of British Columbia so that a similar decision can be made,” said Roche Canada president and CEO Brigitte Nolet.
Bond says the opposition will continue to push the government to reconsider its decision on Kesimpta and Ocrevus. And she hopes patients keep speaking out.
“I think it is important for people to speak up and remind the government, and certainly we are doing that as well, that other jurisdictions have figured this out, have approved it. And MS patients, particularly those that suffer from relapse, are being treated differently in B.C. than the rest of the country,” said Bond.
Stefanek says with the bridge financing from the drug company now over, she can only remain on Kestimpa if it’s covered by Pharmacare.
“As it stands right now, we cannot afford that $19,000. So currently, I’m not on the medication,” she said.
And that has her worried she’s at risk for relapse, which could leave her bedridden and unable to care for her kids.
“I need to keep moving, being able to support them and provide for them,” Stefanek said. “If I’m sick, I’m no good to anybody.”
CTVNews.ca Top Stories
Fluid in eye cells can 'boil' if you watch the eclipse without protection: expert
Millions of people in parts of Eastern and Atlantic Canada will be able to see the rare solar eclipse happening on April 8. But they should only look up if they have proper eye protection, experts say.
He didn't trust police but sought their help anyway. Two days later, he was dead
Jameek Lowery was among more than 330 Black people who died after police stopped them with tactics that aren’t supposed to be deadly, like physical restraint and use of stun guns, The Associated Press found.
CRA no longer requiring 'bare trust' reporting in 2023 tax return
The Canada Revenue Agency announced Thursday it will not require 'bare trust' reporting from Canadians that it introduced for the 2024 tax season, just four days before the April 2 deadline.
Being harassed at work? What to consider when deciding what to do next
If you've been the victim of workplace harassment, it can be difficult to feel you're not alone - and even more difficult to know where to go with a complaint.
Sunshine list: These were the Ontario public sector's highest earners in 2023
Ontario released its annual sunshine list Thursday afternoon, noting that the largest year-over-year increases were in hospitals, municipalities, and post-secondary sectors.
Grandparent scam: London, Ont., senior beats fraudsters not once, but twice
It was a typical Tuesday for Mabel Beharrell, 84, until she got the call that would turn her world upside down. Her teenaged grandson was in trouble and needed her help.
Half of Canadians support TikTok ban, with U.S. concerns 'trickling' north: poll
A new poll indicates 51 per cent of Canadians support banning the social media app TikTok, after a U.S. bill aiming to do just that passed in the House of Representatives.
Where is the worst place for allergy sufferers in Canada?
The spring allergy season has started early in many parts of Canada, with high levels of pollen in some cities already. Experts weigh in on which areas have it worse so far this season.
More unauthorized products for skin, sexual enhancement, recalled: Here are the recalls of this week
Health Canada and the Canadian Food Inspection Agency recalled various items this week, including torches, beef biltong and unauthorized products related to skin care and sexual enhancement.